Colgate-Palmolive Files 8-K on Restructuring Costs & Q2 Earnings Release

Rhea-AI Filing Summary

Colgate-Palmolive (NYSE: CL) filed an 8-K dated 1 Aug 2025 reporting two material items.

• Item 2.02 – Earnings release: The Q2-25 earnings press release was furnished as Exhibit 99; the filing itself contains no revenue, EPS or margin data and is not deemed “filed” for Exchange Act liability purposes.
• Item 2.05 – Three-year Productivity Program: Approved 31 Jul 2025, the initiative is intended to support the company’s 2030 strategy by streamlining the organisational structure and optimising the global supply chain. Management expects cumulative pre-tax charges of $200-$300 million, classified in the Corporate segment, with substantially all costs recognised by 31 Dec 2028.

The company cautions that forward-looking statements about timing and amount of charges may differ materially from current projections. No cost-savings targets, head-count impacts or earnings guidance were disclosed.

Positive

• Strategic realignment: Management launched a three-year Productivity Program aimed at supporting the 2030 strategy and improving supply-chain agility.

Negative

• $200-$300 M pre-tax charges: Restructuring costs will weigh on earnings through 2028.
• No disclosed savings targets: Lack of quantified benefits limits investor ability to assess programme ROI and impact on future margins.

Insights

Equity Research Analyst

TL;DR: New cost-cutting plan adds $200–$300 M charges; long-term benefits unclear due to absent savings targets.

The filing signals management’s intent to boost efficiency via a centrally directed Productivity Program, but investors only know the cost side—$200–$300 M pre-tax through 2028. Without quantified savings, accretion timing to operating margin or EPS can’t be modelled, limiting immediate valuation impact. The program’s recording in the Corporate segment avoids segment-level noise yet still depresses consolidated earnings over the next three years. The simultaneous release of Q2 earnings (details not provided) prevents assessing whether cash generation can comfortably absorb the charges. Overall effect is neutral until savings metrics emerge.

Risk Analyst

TL;DR: Multi-year restructuring introduces execution and forecasting risk without clear benefit disclosure.

The company commits to sizable restructuring charges, but forward-looking disclaimers highlight uncertainty around timing and magnitude. Absence of hard targets on cost reductions, headcount or payback period raises the probability that charges exceed estimates or benefits underdeliver. Investors should monitor subsequent filings for revised cost ranges, impairments or programme modifications, especially given inflationary supply-chain pressures that could erode expected efficiencies.

0000021665False00000216652025-07-312025-07-310000021665us-gaap:CommonStockMember2025-07-312025-07-310000021665cl:A0.500NotesDue2026Member2025-07-312025-07-310000021665cl:A0300NotesDue2029Member2025-07-312025-07-310000021665cl:A1.375NotesDue2034Member2025-07-312025-07-310000021665cl:A0.875Notesdue2039Member2025-07-312025-07-31

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

________________

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

Date of Report (Date of earliest event reported) August 1, 2025 (July 31, 2025)

COLGATE-PALMOLIVE COMPANY

(Exact name of registrant as specified in its charter)

Delaware			1-644			13-1815595
(State or Other Jurisdiction of Incorporation)			(Commission File Number)			(IRS Employer Identification No.)

300 Park Avenue,

New York,

NY

10022

(Address of Principal Executive Offices)

(Zip Code)

                                  

Registrant’s telephone number, including area code (212) 310-2000

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

☐    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Securities 12(b) of the Act:

Title of each class			Trading Symbol(s)			Name of each exchange on which registered
Common Stock, $1.00 par value			CL			New York Stock Exchange
0.500% Notes due 2026			CL26			New York Stock Exchange
0.300% Notes due 2029			CL29			New York Stock Exchange
1.375% Notes due 2034			CL34			New York Stock Exchange
0.875% Notes due 2039			CL39			New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 2.02.    Results of Operations and Financial Condition.

On August 1, 2025, Colgate-Palmolive Company (the “Company”) issued a press release announcing its earnings for the quarter ended June 30, 2025. This press release is attached as Exhibit 99 and is incorporated herein by reference.

The information in Item 2.02 of this Current Report is being furnished and shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that Section. The information in Item 2.02 of this Current Report shall not be incorporated by reference into any registration statement or other document pursuant to the Securities Act of 1933, as amended.

Item 2.05. Costs Associated with Exit or Disposal Activities.

On July 31, 2025, the Company’s Board of Directors approved a new three-year productivity program to drive future growth and support the Company’s 2030 strategy (the “Productivity Program”).

The program includes initiatives to better align the Company’s organizational structure to support its strategic initiatives, optimize the Company’s global supply chain to drive agility and efficiencies and simplify and streamline its organizational structure to reduce overhead costs. The Productivity Program is projected to result in cumulative pre-tax charges, once all initiatives are approved and implemented, totaling between $200 and $300 million over the course of the three-year program. It is expected that substantially all charges resulting from the Productivity Program will be incurred by December 31, 2028.

Charges related to the Productivity Program will be recorded in the Corporate segment as these decisions are predominantly centrally directed and controlled and are not included in internal measures of segment operating performance.

This Current Report on Form 8-K contains forward-looking statements (as that term is defined in the U.S. Private Securities Litigation Reform Act of 1995 or by the Securities and Exchange Commission (“SEC”) in its rules, regulations and releases) about the Productivity Program. These statements are made on the basis of the Company’s views and assumptions as of this time and the Company undertakes no obligation to update these statements unless required by law. These statements are not guarantees of future performance; they involve risks and uncertainties and actual events or results may differ materially from these statements. Potential risks and uncertainties that could cause actual results to differ from expected results include, among others, whether the Company will be able to implement the Productivity Program as planned and whether the estimated amount of charges and the timing thereof resulting from the Productivity Program will differ materially from the current expectations. Investors should consult the Company’s filings with the SEC (including the information set forth under the caption “Risk Factors” in the Company’s Annual Report on Form 10-K for the year ended December 31, 2024 and subsequent filings with the SEC) for information about certain other factors that could cause such differences. Copies of these filings may be obtained upon request from the Company’s Investor Relations Department or on the Company’s web site at http://www.colgatepalmolive.com.

Item 9.01.    Financial Statements and Exhibits.

(d)    Exhibits. The following exhibits are filed with this document:

Exhibit Number			Description
99			Press release, dated August 1, 2025, issued by Colgate-Palmolive Company
104			Cover Page Interactive Data File (embedded within the Inline eXtensible Business Reporting Language (Inline XBRL) document)

2

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.                            

                                               >                 

						COLGATE-PALMOLIVE COMPANY
Date: August 1, 2025						By:    /s/ Stanley J. Sutula III
						Name: Stanley J. Sutula III
						Title: Chief Financial Officer

3

FAQ

What did Colgate-Palmolive (CL) announce in its August 1 2025 8-K?

The 8-K reports a Q2-25 earnings release (Exhibit 99) and approval of a three-year Productivity Program with projected $200-$300 M pre-tax charges.

How much will Colgate-Palmolive's new Productivity Program cost?

Between $200 million and $300 million in cumulative pre-tax charges over three years, mostly booked by 31 Dec 2028.

When will the restructuring charges be recognized?

Management expects substantially all charges to be incurred by December 31, 2028.

Does the filing detail expected cost savings from the Productivity Program?

No. The 8-K outlines expected charges but provides no quantitative savings targets or payback timeline.

Are the Q2 2025 financial results included in the 8-K text?

No. The actual revenue, EPS and margin figures are only in the furnished press release (Exhibit 99), not in the body of the 8-K.